Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
JAMA
|
January 1, 2016
Competition and Biosimilar Products--Reply
Amitabh Chandra, Jacqueline Vanderpuye-Orgle
JAMA
|
July 22, 2015
Competition in the Age of Biosimilars
Amitabh Chandra, Jacqueline Vanderpuye-Orgle
The American Journal of Managed Care
|
June 9, 2016
Does patient cost sharing for HCV drugs make sense?
Darius N Lakdawalla, Mark T Linthicum, Jacqueline Vanderpuye-Orgle
Forum for Health Economics & Policy
|
August 18, 2019
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets
Jacquelyn W Chou, Darius N Lakdawalla, Jacqueline Vanderpuye-Orgle
Current Medical Research and Opinion
|
June 13, 2017
Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature
Nicholas Summers, Jacqueline Vanderpuye-Orgle, Marcia Reinhart, et al.
The American Journal of Managed Care
|
June 19, 2019
Understanding price growth in the market for targeted oncology therapies
Jesse Sussell, Jacqueline Vanderpuye-Orgle, Diana Vania, et al.
The American Journal of Managed Care
|
May 31, 2017
Estimating the social value of G-CSF therapies in the United States
Jacqueline Vanderpuye-Orgle, Alison Sexton Ward, Caroline Huber, et al.
Journal of the American Academy of Dermatology
|
April 18, 2015
Evaluating the economic burden of psoriasis in the United States
Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, et al.
Health Affairs (Project Hope)
|
March 5, 2014
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care
Neeraj Sood, Timothy Juday, Jacqueline Vanderpuye-Orgle, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
September 20, 2014
Impact of oral nutrition supplements on hospital outcomes in pediatric patients
Darius N Lakdawalla, Maria Mascarenhas, Anupam B Jena, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
JAMA
|
January 1, 2016
Competition and Biosimilar Products--Reply
Amitabh Chandra, Jacqueline Vanderpuye-Orgle
JAMA
|
July 22, 2015
Competition in the Age of Biosimilars
Amitabh Chandra, Jacqueline Vanderpuye-Orgle
The American Journal of Managed Care
|
June 9, 2016
Does patient cost sharing for HCV drugs make sense?
Darius N Lakdawalla, Mark T Linthicum, Jacqueline Vanderpuye-Orgle
Forum for Health Economics & Policy
|
August 18, 2019
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets
Jacquelyn W Chou, Darius N Lakdawalla, Jacqueline Vanderpuye-Orgle
Current Medical Research and Opinion
|
June 13, 2017
Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature
Nicholas Summers, Jacqueline Vanderpuye-Orgle, Marcia Reinhart, et al.
The American Journal of Managed Care
|
June 19, 2019
Understanding price growth in the market for targeted oncology therapies
Jesse Sussell, Jacqueline Vanderpuye-Orgle, Diana Vania, et al.
The American Journal of Managed Care
|
May 31, 2017
Estimating the social value of G-CSF therapies in the United States
Jacqueline Vanderpuye-Orgle, Alison Sexton Ward, Caroline Huber, et al.
Journal of the American Academy of Dermatology
|
April 18, 2015
Evaluating the economic burden of psoriasis in the United States
Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, et al.
Health Affairs (Project Hope)
|
March 5, 2014
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care
Neeraj Sood, Timothy Juday, Jacqueline Vanderpuye-Orgle, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
September 20, 2014
Impact of oral nutrition supplements on hospital outcomes in pediatric patients
Darius N Lakdawalla, Maria Mascarenhas, Anupam B Jena, et al.
Page
of 2